Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Finegold

Showing results (351-360 of 382) with videos related to

Pageof 39
Sort By:
Gene Therapy|September 8, 2006
Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vectorK Oka, L M Belalcazar, C Dieker, et al.
Journal of Child Neurology|August 2, 2000
Short-term benefit from oral vancomycin treatment of regressive-onset autismR H Sandler, S M Finegold, E R Bolte, et al.
Journal of Clinical Microbiology|July 1, 1992
Bilophila wadsworthia isolates from clinical specimensE J Baron, M Curren, G Henderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1995
Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug useP H Summanen, D A Talan, C Strong, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1988
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolationG J Cuchural, F P Tally, N V Jacobus, et al.
Nature|May 8, 1997
Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndromeP Zhang, N J Liégeois, C Wong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogsM A Kay, C N Landen, S R Rothenberg, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1984
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982G J Cuchural, F P Tally, N V Jacobus, et al.
Science (New York, N.Y.)|October 1, 1993
In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogsM A Kay, S Rothenberg, C N Landen, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1985
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United StatesF P Tally, G J Cuchural, N V Jacobus, et al.
Pageof 39

Showing results (351-360 of 382) with videos related to

Sort By:
Pageof 39
Gene Therapy|September 8, 2006
Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vectorK Oka, L M Belalcazar, C Dieker, et al.
Journal of Child Neurology|August 2, 2000
Short-term benefit from oral vancomycin treatment of regressive-onset autismR H Sandler, S M Finegold, E R Bolte, et al.
Journal of Clinical Microbiology|July 1, 1992
Bilophila wadsworthia isolates from clinical specimensE J Baron, M Curren, G Henderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1995
Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug useP H Summanen, D A Talan, C Strong, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1988
Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolationG J Cuchural, F P Tally, N V Jacobus, et al.
Nature|May 8, 1997
Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndromeP Zhang, N J Liégeois, C Wong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogsM A Kay, C N Landen, S R Rothenberg, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1984
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982G J Cuchural, F P Tally, N V Jacobus, et al.
Science (New York, N.Y.)|October 1, 1993
In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogsM A Kay, S Rothenberg, C N Landen, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1985
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United StatesF P Tally, G J Cuchural, N V Jacobus, et al.
Pageof 39